On November 14th, according to Vaporvoice, the Food and Drug Administration (FDA) in the United States announced an increase in fines for nicotine companies and retailers who violate various federal laws concerning nicotine products.
This is a section of the 2015 Federal Civil Penalty Inflation Adjustment Act Improvement Act, which mandates fines to be adjusted for inflation. The new fine amounts are as follows:
First violation - $0 (warning letter) 2 violations within 12 months - $345 ($320 originally) 3 violations within 24 months - $687 ($638 originally) 4 violations within 24 months - $2,757 ($2,559 originally) 5 violations within 36 months - $6,892 ($6,397 originally) 6 violations within 48 months - $13,785 ($12,794 originally)
Civil fines of this nature apply to e-cigarette and other tobacco companies or retailers found to be in violation of regulations set forth by the Food and Drug Administration regarding e-cigarettes and other tobacco products. This includes instances where e-cigarette companies fail to use appropriate warning labels, or retailers neglect to verify the age of buyers when selling any nicotine products.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
